Tag Archives: Glioblastoma

01Dec/23

Oncolytic Virus Therapy CAN-3110 Shows Promise in Treating Aggressive Brain Cancer Glioblastoma

December 1, 2023Oncolytic Virus News, Oncolytic Virus ResearchCAN-3110, Glioblastoma, Oncolytic Virus Therapybiolabs

Glioblastoma (GBM) is an aggressive brain cancer known for its resistance to treatment, with patients experiencing recurrent GBM having a survival period of less than 10 months. Immunotherapy, which mobilizes the body’sRead More…

18May/23

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma

Novel AAV-Based Immunotherapy May Help Immune System Clear Glioblastoma

May 18, 2023Cancer ImmunotherapyAAV-Based Immunotherapy, AAV-LIGHT therapy, Glioblastomabiolabs

Glioblastomas are aggressive brain tumors that are largely resistant to immunotherapy, perhaps related to immunosuppression and dysfunctional tumor vasculature, which tend to impede T-cell infiltration. LIGHT, which is also known as tumorRead More…

Oncolytic Virus Research
Oncolytic Virus News